Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Matrix announces restructuring to focus on oncology products

Oct. 1, 1997

Inex seeks Canadian approval to commence Onco TCS trials for lymphoma

Sep. 30, 1997

Taxotere efficacy demonstrated in NSCLC, gastric cancer

Sep. 29, 1997

Cancer gene therapy shows long-term benefits in mice

Sep. 29, 1997

New taxoids with improved anticancer activity

Sep. 26, 1997

Pierre Fabre develops novel anticancer carpaine derivatives

Sep. 26, 1997

Nonsteroidal inhibitors of steroid C17,20-lyase developed at Yamanouchi

Sep. 25, 1997

Novartis prepares protein tyrosine kinase inhibitors

Sep. 25, 1997

Lisofylline collaboration expanded to include AML

Sep. 24, 1997

p53 phase II trial for head and neck cancer

Sep. 24, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
JPM 2026: Year kicks off with biopharma Q4 revenue and guidance
BioWorld
It was a battle of the companies with drugs for transthyretin-mediated amyloidosis on the first day of the J.P. Morgan 2026 Healthcare Conference with Alnylam...